Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 study.

ABSTRACT:

SUBMITTER: Shi Y 

PROVIDER: S-EPMC11845196 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature